Evidence map›Paper›PMID 24062574›Full record

ArticleRNA (New York, N.Y.)2013

MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases.

Sreenivas Chavali, Sören Bruhn, Katrin Tiemann, Pål Saetrom, Fredrik Barrenäs, Takaya Saito, Kartiek Kanduri, Hui Wang, Mikael Benson

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Ghrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  8. Article
  9. Article
  10. MicroRNAs in Palatogenesis and Cleft Palate.Frontiers in physiology · 2017
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Sreenivas Chavali
Sören Bruhn
Katrin Tiemann
Pål Saetrom
Fredrik Barrenäs
Takaya Saito
Kartiek Kanduri
Hui Wang
Mikael Benson
Linköping University Hospital · SENorwegian University of Science and Technology · NODrottning Silvias barn- och ungdomssjukhus · SEMRC Laboratory of Molecular Biology · GBUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) play a key role in regulating mRNA expression, and individual miRNAs have been proposed as diagnostic and therapeutic candidates. The identification of such candidates is complicated by the involvement of multiple miRNAs and mRNAs as well as unknown disease topology of the miRNAs. Here, we investigated if disease-associated miRNAs regulate modules of disease-associated mRNAs, if those miRNAs act complementarily or synergistically, and if single or combinations of miRNAs can be targeted to alter module functions. We first analyzed publicly available miRNA and mRNA expression data for five different diseases. Integrated target prediction and network-based analysis showed that the miRNAs regulated modules of disease-relevant genes. Most of the miRNAs acted complementarily to regulate multiple mRNAs. To functionally test these findings, we repeated the analysis using our own miRNA and mRNA expression data from CD4+ T cells from patients with seasonal allergic rhinitis. This is a good model of complex diseases because of its well-defined phenotype and pathogenesis. Combined computational and functional studies confirmed that miRNAs mainly acted complementarily and that a combination of two complementary miRNAs, miR-223 and miR-139-3p, could be targeted to alter disease-relevant module functions, namely, the release of type 2 helper T-cell (Th2) cytokines. Taken together, our findings indicate that miRNAs act complementarily to regulate modules of disease-related mRNAs and can be targeted to alter disease-relevant functions.

Indexed as

Carcinoma, Renal CellDiabetes Mellitus, Type 2Gene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansInterleukin-13Interleukin-5Kidney NeoplasmsMicroRNAsPancreatic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaPulmonary Disease, Chronic ObstructiveRhinitis, Allergic, SeasonalRNA, MessengerTh2 CellsInterleukin-13Interleukin-5MicroRNAsMIR223, humanMIRN139 microRNA, humanRNA, MessengerdiseasesmicroRNAmodulesregulation

Identifiers

PMID24062574
PMCPMC3851722
OpenAlexW2134324848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.